Keefe Bruyette analyst Meyer Shields raised the firm’s price target on The Hanover (THG) to $207 from $200 and keeps an Outperform rating on the shares. The shares’ current valuation underappreciates the ongoing margin-expanding rate increases within its Core Commercial and Specialty segments, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on THG:
- Hanover Insurance Posts Record ROE, Targets Profitable 2026
- Hold Rating Sustained as Hanover’s Margin Strength Offsets Growth Headwinds
- The Hanover reports Q4 non-GAAP EPS $5.79, consensus $5.03
- THG Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- Hanover Insurance Announces Redemption of 2026 Notes
